<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36178611</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Current cardiology reports</Title><ISOAbbreviation>Curr Cardiol Rep</ISOAbbreviation></Journal><ArticleTitle>Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems.</ArticleTitle><Pagination><StartPage>1711</StartPage><EndPage>1726</EndPage><MedlinePgn>1711-1726</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11886-022-01786-2</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">Long-COVID syndrome is a multi-organ disorder that persists beyond 12&#xa0;weeks post-acute SARS-CoV-2 infection (COVID-19). Here, we provide a definition for this syndrome and discuss neuro-cardiology involvement due to the effects of (1) angiotensin-converting enzyme 2 receptors (the entry points for the virus), (2) inflammation, and (3) oxidative stress (the resultant effects of the virus).</AbstractText><AbstractText Label="RECENT FINDINGS">These effects may produce a spectrum of cardio-neuro effects (e.g., myocardial injury, primary arrhythmia, and cardiac symptoms due to autonomic dysfunction) which may affect all systems of the body. We discuss the symptoms and suggest therapies that target the underlying autonomic dysfunction to relieve the symptoms rather than merely treating symptoms. In addition to treating the autonomic dysfunction, the therapy also treats chronic inflammation and oxidative stress. Together with a full noninvasive cardiac workup, a full assessment of the autonomic nervous system, specifying parasympathetic and sympathetic (P&amp;S) activity, both at rest and in response to challenges, is recommended. Cardiac symptoms must be treated directly. Cardiac treatment is often facilitated by treating the P&amp;S dysfunction. Cardiac symptoms of dyspnea, chest pain, and palpitations, for example, need to be assessed objectively to differentiate cardiac from neural (autonomic) etiology. Long-term myocardial injury commonly involves P&amp;S dysfunction. P&amp;S assessment usually connects symptoms of Long-COVID to the documented autonomic dysfunction(s).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DePace</LastName><ForeName>Nicholas L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Franklin Cardiovascular Associates, PA - Autonomic Dysfunction and POTS Center, Sicklerville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuro-Cardiology Research Corporation, LLC, Wilmington, DE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Franklin Cardiovascular Associates, PA - Autonomic Dysfunction and POTS Center, Sicklerville, NJ, USA. dovetech@erols.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuro-Cardiology Research Corporation, LLC, Wilmington, DE, USA. dovetech@erols.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CTO and Sr. Medical Director, Physio PS, Inc, Atlanta, GA, USA. dovetech@erols.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Cardiol Rep</MedlineTA><NlmUniqueID>100888969</NlmUniqueID><ISSNLinking>1523-3782</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002319" MajorTopicYN="Y">Cardiovascular System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Neuro-cardiovascular effects</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList><CoiStatement>Dr. Colombo reports the following: inventor of P&amp;S Monitoring technology and officer of Physio PS, Inc. NeuroCardiology Research Corp. has no interest or involvement in this work. The other author has no disclosures to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36178611</ArticleId><ArticleId IdType="pmc">PMC9524329</ArticleId><ArticleId IdType="doi">10.1007/s11886-022-01786-2</ArticleId><ArticleId IdType="pii">10.1007/s11886-022-01786-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76:533&#x2013;546. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi AA, Rivas-Lasarte M, et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. J Am Coll Cardiol. 2020;76:2334&#x2013;2348. doi: 10.1016/j.jacc.2020.09.549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.09.549</ArticleId><ArticleId IdType="pmc">PMC7598769</ArticleId><ArticleId IdType="pubmed">33129663</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JQ, Lu JY, Wang W, Liu Y, Buczek A, Fleysher R, et al. Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19: predictors of acute cardiac injury recovery in COVID-19. EBioMedicine. 2022;76:103821. doi: 10.1016/j.ebiom.2022.103821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103821</ArticleId><ArticleId IdType="pmc">PMC8819639</ArticleId><ArticleId IdType="pubmed">35144887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen ME, Abramoff B. COVID-19: Evaluation and management of adults following acute viral illness - UpToDate. Available at: https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-adults-following-acute-viral-illness. Accessed 1 Jul&#xa0;2022.</Citation></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020; 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19, National Institute for Health and Care Excellence (UK). 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G, Newcomb R, Cowl CT, et al. Post-COVID-19 syndrome (long haul syndrome): description of a multidisciplinary clinic at Mayo Clinic and characteristics of the initial patient cohort. Mayo Clin Proc. 2021;96:1782. doi: 10.1016/j.mayocp.2021.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022 doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada Y, Suzuki J. Oxidative stress and myocarditis. Curr Pharm Des. 2016;22(4):450&#x2013;471. doi: 10.2174/1381612822666151222160559.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151222160559</ArticleId><ArticleId IdType="pubmed">26696256</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;scher TF. Ageing, inflammation, and oxidative stress: final common pathways of cardiovascular disease. Eur Heart J. 2015;36(48):3381&#x2013;3383. doi: 10.1093/eurheartj/ehv679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv679</ArticleId><ArticleId IdType="pubmed">26690751</ArticleId></ArticleIdList></Reference><Reference><Citation>Mito S, Thandavarayan RA, Ma M, Lakshmanan A, Suzuki K, Kodama M, et al. Inhibition of cardiac oxidative and endoplasmic reticulum stress-mediated apoptosis by curcumin treatment contributes to protection against acute myocarditis. Free Radic Res. 2011;45(10):1223&#x2013;1231. doi: 10.3109/10715762.2011.607252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2011.607252</ArticleId><ArticleId IdType="pubmed">21781008</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12(6):1562. doi: 10.3390/nu12061562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061562</ArticleId><ArticleId IdType="pmc">PMC7352291</ArticleId><ArticleId IdType="pubmed">32471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res. 2020;51(5):384&#x2013;387. doi: 10.1016/j.arcmed.2020.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.04.019</ArticleId><ArticleId IdType="pmc">PMC7190501</ArticleId><ArticleId IdType="pubmed">32402576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway. Oxid Med Cell Longev. 2018;31(2018):6208067. doi: 10.1155/2018/6208067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6208067</ArticleId><ArticleId IdType="pmc">PMC6234444</ArticleId><ArticleId IdType="pubmed">30515256</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhail S, Zajac J, Fossum C, Lowater H, McCracken C, Severson N, et al. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. Protein J. 2020;39(6):644&#x2013;656. doi: 10.1007/s10930-020-09935-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-020-09935-8</ArticleId><ArticleId IdType="pmc">PMC7587547</ArticleId><ArticleId IdType="pubmed">33106987</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Garc&#xed;a J, Osca-Verdegal R, Pallard&#xf3; FV, Ferreres J, Rodr&#xed;guez M, Mulet S, et al. Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants (Basel) 2020;9(10):936. doi: 10.3390/antiox9100936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9100936</ArticleId><ArticleId IdType="pmc">PMC7599810</ArticleId><ArticleId IdType="pubmed">33003552</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2018;16(1):268. 10.1186/s12967-018-1644-y. PMID: 30285773; PMCID: PMC6167797. This manuscript provides the basis for the central figure to our review, demonstrating the association between viruses, including COVID-19, and other traumas (both mental and physical), and oxidative stress, which in turn is associated with parasympathetic and sympathetic dysfunctions known as dysautonomias that are associated with Long-COVID syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>da Cunha NV, Lopes FN, Panis C, Cecchini R, Pinge-Filho P, Martins-Pinge MC. iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats. Clin Exp Hypertens. 2017;39(1):50&#x2013;57. doi: 10.1080/10641963.2016.1210628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10641963.2016.1210628</ArticleId><ArticleId IdType="pubmed">28055264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeldtke RD, Bryner KD, VanDyke K. Oxidative stress and autonomic nerve function in early type 1 diabetes. Clin Auton Res. 2011;21(1):19&#x2013;28. doi: 10.1007/s10286-010-0084-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-010-0084-4</ArticleId><ArticleId IdType="pubmed">20872157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler D, Buchholz S, Sohr C, Nourooz-Zadeh J, Roden M. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients. Acta Diabetol. 2015;52(1):65&#x2013;72. doi: 10.1007/s00592-014-0601-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-014-0601-3</ArticleId><ArticleId IdType="pubmed">24898524</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo J, Weintraub MI, Munoz R, Verma A, Ahmed G, Kaczmarski K, et al. Long-COVID and the autonomic nervous system: the journey from dysautonomia to therapeutic neuro-modulation, analysis of 152 patient retrospectives. NeuroSci. 2022;3(2):300&#x2013;310. doi: 10.3390/neurosci3020021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurosci3020021</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-acute COVID-19 syndrome and the cardiovascular system: what is known? Am Heart J Plus. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Deng KQ, Li C, Yang Z, Hu H, Cai H, et al. Cardiac involvement in recovered patients from COVID-19: a preliminary 6-month follow-up study. Front Cardiovasc Med. 2021;13(8):654405. doi: 10.3389/fcvm.2021.654405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.654405</ArticleId><ArticleId IdType="pmc">PMC8155269</ArticleId><ArticleId IdType="pubmed">34055936</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento BR, Sable C. Cardiac involvement in COVID-19: cause or consequence of severe manifestations? Heart. 2022;108(1):7&#x2013;8. doi: 10.1136/heartjnl-2021-320246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-320246</ArticleId><ArticleId IdType="pubmed">34656975</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J. The COVID heart-one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks. JAMA. 2022;327(12):1113&#x2013;1114. doi: 10.1001/jama.2022.2411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2411</ArticleId><ArticleId IdType="pubmed">35234824</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV, III, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128(8):1214&#x2013;1236. doi: 10.1161/CIRCRESAHA.121.317997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasecka A, Pruc M, Kukula K, Gilis-Malinowska N, Filipiak KJ, Jaguszewski MJ, et al. Post-COVID-19 heart syndrome. Cardiol J. 2021;28(2):353&#x2013;354. doi: 10.5603/CJ.a2021.0028.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0028</ArticleId><ArticleId IdType="pmc">PMC8078939</ArticleId><ArticleId IdType="pubmed">33645626</ArticleId></ArticleIdList></Reference><Reference><Citation>Aeschlimann FA, Misra N, Hussein T, Panaioli E, Soslow JH, Crum K, et al. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson. 2021;23(1):140. doi: 10.1186/s12968-021-00841-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00841-1</ArticleId><ArticleId IdType="pmc">PMC8717054</ArticleId><ArticleId IdType="pubmed">34969397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale J. Heart damage plagues COVID survivors a year after infection, study shows. 12:10 AM EST, 2021. https://www.bloombergquint.com/coronavirus-outbreak/heart-damage-racks-covid-survivors-a-year-after-infection-study.&#xa0;Accessed 15 Feb&#xa0;2022.</Citation></Reference><Reference><Citation>Komiyama M, Hasegawa K, Matsumori A. Dilated cardiomyopathy risk in patients with coronavirus disease 2019: how to identify and characterise it early? Eur Cardiol. 2020;27(15):e49. doi: 10.15420/ecr.2020.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2020.17</ArticleId><ArticleId IdType="pmc">PMC7277785</ArticleId><ArticleId IdType="pubmed">32536978</ArticleId></ArticleIdList></Reference><Reference><Citation>Revzin MV, Raza S, Srivastava NC, Warshawsky R, D'Agostino C, Malhotra A, et al. Multisystem imaging manifestations of COVID-19, part 2: from cardiac complications to pediatric manifestations. Radiographics. 2020;40(7):1866&#x2013;1892. doi: 10.1148/rg.2020200195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2020200195</ArticleId><ArticleId IdType="pmc">PMC7646410</ArticleId><ArticleId IdType="pubmed">33136488</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem imaging manifestations of COVID-19, part 2: from cardiac complications to pediatric manifestations. Radiographics. 2020;40(7):1866&#x2013;1892. doi: 10.1148/rg.2020200195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2020200195</ArticleId><ArticleId IdType="pmc">PMC7646410</ArticleId><ArticleId IdType="pubmed">33136488</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for disease control and prevention. Post-COVID conditions: information for healthcare providers. 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. Accessed 1 Jul&#xa0;2022.</Citation></Reference><Reference><Citation>World Health Organization. ICD-10 : international statistical classification of diseases and related health problems: tenth revision, 2nd ed. World Health Organization. 2004. https://apps.who.int/iris/handle/10665/42980. Accessed 15 Feb&#xa0;2022.</Citation></Reference><Reference><Citation>DePace NL, Colombo J. Long-COVID syndrome: a multi-organ disorder. Cardio Open. 2022;7(1):213&#x2013;224. doi: 10.33140/COA.07.01.07.</Citation><ArticleIdList><ArticleId IdType="doi">10.33140/COA.07.01.07</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne). 2021;8:653516. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Afrin LB, Self S, Menk J, Lazarchick J. Characterization of mast cell activation syndrome. Am J Med Sci. 2017;353(3):207&#x2013;215. doi: 10.1016/j.amjms.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5341697</ArticleId><ArticleId IdType="pubmed">28262205</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal AA, et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis. 2021;8(11):156. doi: 10.3390/jcdd8110156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8110156</ArticleId><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E. The Long-COVID, COVID-19 is starting to be addressed on major newsapapers in Italy too: ~20% of tested patients remain COVID+ for at least 40 days. Professor from Tor Vergata University of Rome notes: there is a lot we don&#x2019;t know about this virus. 20 May 2020. https://twitter.com/elisaperego78/status/1263172084055838721.&#xa0;Accessed 15 Feb&#xa0;2022.</Citation></Reference><Reference><Citation>NBC Nightly News. COVID-19 &#x2018;longhaulers&#x2019; report nearly 100 symptoms for more than 100 days. 20 July 2020. https://www.nbcnews.com/nightly-news-netcast/video/nightly-news-full-broadcast-july-31st-89377349826.&#xa0;Accessed 15 Feb&#xa0;2022.</Citation></Reference><Reference><Citation>Yong E. Even health-care workers with Long-COVID are being dismissed. 24 November 2021. https://www.theatlantic.com/health/archive/2021/11/health-care-workers-long-covid-are-being-dismissed/620801/.&#xa0;Accessed 15 Feb&#xa0;2022.</Citation></Reference><Reference><Citation>Garg P, Arora U, Kumar A, Wig N. The, &#x201c;post-COVID&#x201d; syndrome: how deep is the damage? J Med Virol. 2021;93(2):673&#x2013;674. doi: 10.1002/jmv.26465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26465</ArticleId><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi FG. Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: how to define it and how to manage it. BMJ. 2020;7(370):m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Barrett KMS, Riffle S, Bolze A, Neveux I, Dabe S, et al. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020. 10.1101/2020.10.07.20208702.</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias H, Vinitsky A, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic nervous system monitoring of patients with excess parasympathetic responses to sympathetic challenges &#x2013; clinical observations. US Neurology. 2010;5(2):62&#x2013;66. doi: 10.17925/USN.2010.05.02.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.17925/USN.2010.05.02.62</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo J, Arora RR, DePace NL, Vinik AI. Clinical autonomic dysfunction: measurement, indications, therapies, and outcomes. Springer Science + Business Media, New York, NY, 2014.</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D and Pawelek P. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 July 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1july2021.&#xa0;Accessed 15 Feb&#xa0;2022.</Citation></Reference><Reference><Citation>Monteil V, Kwon H, Prado P, Hagelkr&#xfc;ys A, Wimmer RA, Stahl M, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181:905&#x2013;913.e7. doi: 10.1016/j.cell.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Qaradakhi T, Gadanec LK, McSweeney KR, Tacey A, Apostolopoulos V, Levinger I, et al. The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clin Exp Pharmacol Physiol. 2020;47:751&#x2013;758. doi: 10.1111/1440-1681.13251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.13251</ArticleId><ArticleId IdType="pubmed">31901211</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;11(370):m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DS, Kotecha T, Razvi Y. COVID-19: myocardial injury in survivors. Circulation. 2020;142(11):1120&#x2013;1122. doi: 10.1161/circulationaha.120.049252.Sep15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.120.049252.Sep15</ArticleId><ArticleId IdType="pmc">PMC7492396</ArticleId><ArticleId IdType="pubmed">32673505</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021 doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker RC. Toward understanding the 2019 Coronavirus and its impact on the heart. J Thromb Thrombolysis. 2020;50(1):33&#x2013;42. doi: 10.1007/s11239-020-02107-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02107-6</ArticleId><ArticleId IdType="pmc">PMC7156795</ArticleId><ArticleId IdType="pubmed">32297133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol. 2021;77(3):314&#x2013;325. doi: 10.1016/j.jacc.2020.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL, Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244&#x2013;1258. doi: 10.1016/j.jacc.2020.06.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.068</ArticleId><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2043&#x2013;2055. doi: 10.1016/j.jacc.2020.08.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.069</ArticleId><ArticleId IdType="pmc">PMC7588179</ArticleId><ArticleId IdType="pubmed">33121710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng JH, Wu WB, Qu JX, Wang Y, Dong CF, Luo YF, et al. Cardiac manifestations of COVID-19 in Shenzhen, China. Infection. 2020;48:861&#x2013;870. doi: 10.1007/s15010-020-01473-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01473-w</ArticleId><ArticleId IdType="pmc">PMC7386384</ArticleId><ArticleId IdType="pubmed">32725595</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6(1):116&#x2013;118. doi: 10.1001/jamacardio.2020.4916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141(6):e69&#x2013;e92. doi: 10.1161/CIR.0000000000000745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000745</ArticleId><ArticleId IdType="pubmed">31902242</ArticleId></ArticleIdList></Reference><Reference><Citation>Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg. 2020;140:49&#x2013;53. doi: 10.1016/j.wneu.2020.05.193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.05.193</ArticleId><ArticleId IdType="pmc">PMC7255736</ArticleId><ArticleId IdType="pubmed">32474093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Stremel RW, Convertino VA, Bernauer EM, Greenleaf JE. Cardiorespiratory deconditioning with static and dynamic leg exercise during bed rest. J Appl Physiol. 1976;41(6):905&#x2013;909. doi: 10.1152/jappl.1976.41.6.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1976.41.6.905</ArticleId><ArticleId IdType="pubmed">1002644</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyner MJ, Masuki S. POTS versus deconditioning: the same or different? Clin Auton Res. 2008;18(6):300&#x2013;307. doi: 10.1007/s10286-008-0487-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-008-0487-7</ArticleId><ArticleId IdType="pmc">PMC3770293</ArticleId><ArticleId IdType="pubmed">18704621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Place S. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335&#x2013;344. doi: 10.1111/joim.13089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13089</ArticleId><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group, Morin L, Savale L, Pham T, et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021; PMID 33729425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Novac E. Neurologicals. 2021;21:100&#x2013;276.</Citation></Reference><Reference><Citation>Miglis MG, Goodman BP, Ch&#xe9;mali KR, Stiles L, et al. Re: &#x2018;Post-COVID-19 chronic symptoms&#x2019; by Davido. Clin Microbiol Infect. 2021;27(3):494. doi: 10.1016/j.cmi.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7470728</ArticleId><ArticleId IdType="pubmed">32891765</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakusic A, Rabinstein AA. Cognitive outcomes after critical illness. Curr Opin Crit Care. 2018;24(5):410&#x2013;414. doi: 10.1097/MCC.0000000000000527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000527</ArticleId><ArticleId IdType="pubmed">30036191</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora RR, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic mechanisms and therapeutic implications of postural diabetic cardiovascular abnormalities. J Diabetes Sci Technol. 2008;2(4):568&#x2013;571. doi: 10.1177/193229680800200416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229680800200416</ArticleId><ArticleId IdType="pmc">PMC2769753</ArticleId><ArticleId IdType="pubmed">19885241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci A. International AIDS Conference: YouTube 2020 and Nordvigas. Potential neurological manifestations of COVID-19. Neurology Clin Pract. 18 March 2020.</Citation></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Belvis R. Headaches during COVID-19: my clinical case and review of the literature. Headache. 2020;60(7):1422&#x2013;1426. doi: 10.1111/head.13841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13841</ArticleId><ArticleId IdType="pmc">PMC7273035</ArticleId><ArticleId IdType="pubmed">32413158</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozo-Rosich P. Virtual annual scientific meetings - Advances in Headache science. 17 July 2020.</Citation></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Henek A. Alzheimer&#x2019;s research therapeutics. 2020;1269.</Citation></Reference><Reference><Citation>Kaseda ET, Levine AJ. Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020;34(7&#x2013;8):1498&#x2013;1514. doi: 10.1080/13854046.2020.1811894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1811894</ArticleId><ArticleId IdType="pubmed">32847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankisi H, Tankisi A, Harbo T, Markvardsen LK, Andersen H, Pedersen TH. Critical illness myopathy as a consequence of COVID-19 infection. Clin Neurophysiol. 2020;131(8):1931&#x2013;1932. doi: 10.1016/j.clinph.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7834604</ArticleId><ArticleId IdType="pubmed">32619798</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120(9):725&#x2013;734. doi: 10.1161/CIRCULATIONAHA.108.846501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.846501</ArticleId><ArticleId IdType="pmc">PMC2758650</ArticleId><ArticleId IdType="pubmed">19687359</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik G.R. medRxiv Vol 20, 2020:July 06.</Citation></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Lond) 2021;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021;27(1):191&#x2013;195. doi: 10.1007/s13365-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak E. Neurological science. 2020.</Citation></Reference><Reference><Citation>Rahimi MM. BMJ Case Rep. 2021;14e:240178.</Citation></Reference><Reference><Citation>Hosey MM, Needham DM. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020;6(1):60. doi: 10.1038/s41572-020-0201-1.PMID:32669623;PMCID:PMC7362322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0201-1.PMID:32669623;PMCID:PMC7362322</ArticleId><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87(12):1196&#x2013;1201. doi: 10.1016/j.mayocp.2012.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Y, Rojas M, Ram&#xed;rez-Santana C, Acosta-Ampudia Y, Monsalve DM, Anaya JM. Autonomic symptoms following Zika virus infection. Clin Auton Res. 2018;28(2):211&#x2013;214. doi: 10.1007/s10286-018-0515-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-018-0515-1</ArticleId><ArticleId IdType="pubmed">29497887</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, Rodr&#xed;guez Y, Roa G, Lozano M, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20(11):102947. doi: 10.1016/j.autrev.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic hypotension: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(11):1294&#x2013;1309. doi: 10.1016/j.jacc.2018.05.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.05.079</ArticleId><ArticleId IdType="pubmed">30190008</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J. The pathophysiology of the vasovagal response. Heart Rhythm. 2018;15(6):921&#x2013;929. doi: 10.1016/j.hrthm.2017.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2017.12.013</ArticleId><ArticleId IdType="pmc">PMC5984661</ArticleId><ArticleId IdType="pubmed">29246828</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, et al. Preventing cytokine storm syndrome in COVID-19 using &#x3b1;-1 adrenergic receptor antagonists. J Clin Invest. 2020;130(7):3345&#x2013;3347. doi: 10.1172/JCI139642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139642</ArticleId><ArticleId IdType="pmc">PMC7324164</ArticleId><ArticleId IdType="pubmed">32352407</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M, Qadri YJ, Ghadimi K, MacLeod DB, Molinger J, Piccini JP, et al. Implications for neuromodulation therapy to control inflammation and related organ dysfunction in COVID-19. J Cardiovasc Transl Res. 2020;13(6):894&#x2013;899. doi: 10.1007/s12265-020-10031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-020-10031-6</ArticleId><ArticleId IdType="pmc">PMC7250255</ArticleId><ArticleId IdType="pubmed">32458400</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilmot A, Maldonado Slootjes S, Sellimi A, Bronchain M, Hanseeuw B, Belkhir L, et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021;268(3):751&#x2013;757. doi: 10.1007/s00415-020-10108-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10108-x</ArticleId><ArticleId IdType="pmc">PMC7391231</ArticleId><ArticleId IdType="pubmed">32734353</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q, Vangundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension. 2011;58(2):167&#x2013;175. doi: 10.1161/HYPERTENSIONAHA.111.172262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.172262</ArticleId><ArticleId IdType="pmc">PMC3142863</ArticleId><ArticleId IdType="pubmed">21690484</ArticleId></ArticleIdList></Reference><Reference><Citation>DePace NL, Vinik AI, Acosta CR, Eisen HJ, Colombo J. Oral vasoactive medications a summary of midodrine and droxidopa as applied to orthostatic dysfunction. Cardio Open. 2022;7(1):225&#x2013;241.</Citation></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study. J Neurol. 2022;269(2):587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan MT, Pan XQ, Smith AL, Newman DK, Weiss SR, Ruggieri MR, Sr, et al. Coronavirus-induced demyelination of neural pathways triggers neurogenic bladder overactivity in a mouse model of multiple sclerosis. Am J Physiol Renal Physiol. 2014;307(5):F612&#x2013;F622. doi: 10.1152/ajprenal.00151.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00151.2014</ArticleId><ArticleId IdType="pmc">PMC4154110</ArticleId><ArticleId IdType="pubmed">25007876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourfridoni M, Pajokh M, Seyedi F. Bladder and bowel incontinence in COVID-19. J Med Virol. 2021;93(5):2609&#x2013;2610. doi: 10.1002/jmv.26849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26849</ArticleId><ArticleId IdType="pmc">PMC8014136</ArticleId><ArticleId IdType="pubmed">33543786</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W, et al. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest. 2021;44(2):223&#x2013;231. doi: 10.1007/s40618-020-01350-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01350-1</ArticleId><ArticleId IdType="pmc">PMC7355084</ArticleId><ArticleId IdType="pubmed">32661947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Ciocca G, Colonnello E, Limoncin E, Balercia G, et al. &#x201c;Mask up to keep it up&#x201d;: preliminary evidence of the association between erectile dysfunction and COVID-19. Andrology. 2021;9(4):1053&#x2013;1059. doi: 10.1111/andr.13003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13003</ArticleId><ArticleId IdType="pmc">PMC8250520</ArticleId><ArticleId IdType="pubmed">33742540</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831&#x2013;1833.e3. doi: 10.1053/j.gastro.2020.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;nguez-Varela IA, Rodr&#xed;guez-Guti&#xe9;rrez LA, Morales-Mancillas NR, Barrera-S&#xe1;nchez M, Mac&#xed;as-Rodr&#xed;guez Y, Valdez-Garc&#xed;a JE. COVID-19 and the eye: a review. Infect Dis (Lond) 2021;53(6):399&#x2013;403. doi: 10.1080/23744235.2021.1882697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1882697</ArticleId><ArticleId IdType="pubmed">33566704</ArticleId></ArticleIdList></Reference><Reference><Citation>Karahan M, Demirta&#x15f; AA, Hazar L, Erdem S, Ava S, Dursun ME, et al. Autonomic dysfunction detection by an automatic pupillometer as a non-invasive test in patients recovered from COVID-19. Graefes Arch Clin Exp Ophthalmol. 2021;259(9):2821&#x2013;2826. doi: 10.1007/s00417-021-05209-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05209-w</ArticleId><ArticleId IdType="pmc">PMC8078384</ArticleId><ArticleId IdType="pubmed">33907887</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman BP, Khoury JA, Blair JE, Grill MF. COVID-19 dysautonomia. Front Neurol. 2021;13(12):624968. doi: 10.3389/fneur.2021.624968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N, Le Guen M, Russel S, et al. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021;11:14042. doi: 10.1038/s41598-021-93546-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31(3):385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69(2):205&#x2013;211. doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al. Post&#x2013;COVID-19 respiratory complications. Annals ATS. 2021;18(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513647</ArticleId><ArticleId IdType="pubmed">33596163</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;20(8):20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, Buchwald D, Crawley E, Hautvast J, et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. 2021;8(10):ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatoon F, Prasad K, Kumar V. Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol. 2020;26(5):619&#x2013;630. doi: 10.1007/s13365-020-00895-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00895-4</ArticleId><ArticleId IdType="pmc">PMC7444681</ArticleId><ArticleId IdType="pubmed">32839951</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Li M, Ou G. COVID-19, cilia, and smell. FEBS J. 2020;287(17):3672&#x2013;3676. doi: 10.1111/febs.15491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15491</ArticleId><ArticleId IdType="pmc">PMC7426555</ArticleId><ArticleId IdType="pubmed">32692465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar D, Baig AM, Wasay M. Neurological manifestations of COVID-19. J Pak Med Assoc. 2020;70(Suppl 3(5)):S101&#x2013;S103. doi: 10.5455/JPMA.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/JPMA.20</ArticleId><ArticleId IdType="pubmed">32515379</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetlow S, Segiet-Swiecicka A, O'Sullivan R, O'Halloran S, Kalb K, Brathwaite-Shirley C, et al. ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19. J Intern Med. 2021;289(5):688&#x2013;699. doi: 10.1111/joim.13202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13202</ArticleId><ArticleId IdType="pmc">PMC7753609</ArticleId><ArticleId IdType="pubmed">33210357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Liang B, Chen C, et al. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19. Nat Commun. 2021;12:1813. doi: 10.1038/s41467-021-22034-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22034-1</ArticleId><ArticleId IdType="pmc">PMC7985370</ArticleId><ArticleId IdType="pubmed">33753738</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey J, Alam MT, Chandra S, Gupta J, Ray U, Srivastava AK, Tripathi PP. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain. J Med Virol. 2021;93(3):1296&#x2013;1303. 10.1002/jmv.26521. Epub 2020 Sep 28. PMID: 32964419.</Citation><ArticleIdList><ArticleId IdType="pubmed">32964419</ArticleId></ArticleIdList></Reference><Reference><Citation>Toljan K. Letter to the editor regarding the viewpoint &#x201c;Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanism&#x201d;. ACS Chem Neurosci. 2020;11(8):1192&#x2013;1194. doi: 10.1021/acschemneuro.0c00174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00174</ArticleId><ArticleId IdType="pubmed">32233443</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid-19-induced dysautonomia: a menace of sympathetic storm. ASN Neuro. 2021;13:17590914211057635. doi: 10.1177/17590914211057635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17590914211057635</ArticleId><ArticleId IdType="pmc">PMC8586167</ArticleId><ArticleId IdType="pubmed">34755562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinduja A, Moutairou A, Calvet JH. Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiol Clin. 2021;51(2):193&#x2013;196. doi: 10.1016/j.neucli.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7835104</ArticleId><ArticleId IdType="pubmed">33551341</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vall&#xe9;e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021;11(1):14042. doi: 10.1038/s41598-021-93546-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker RC. Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor&#x2019;s page series. J Thromb Thrombolysis. 2021;52(3):692&#x2013;707. doi: 10.1007/s11239-021-02549-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02549-6</ArticleId><ArticleId IdType="pmc">PMC8367772</ArticleId><ArticleId IdType="pubmed">34403043</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;26(374):n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A. Post-acute COVID-19 syndrome. Nat Med. 2021 doi: 10.1038/s41591-021-01283-z.2021/03/22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z.2021/03/22</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-215818.Nov10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818.Nov10</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeghate EA, Eid N, Singh J. Mechanisms of COVID-19-induced heart failure: a short review. Heart Fail Rev. 2021;26(2):363&#x2013;369. doi: 10.1007/s10741-020-10037-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-020-10037-x</ArticleId><ArticleId IdType="pmc">PMC7666972</ArticleId><ArticleId IdType="pubmed">33191474</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2021;118(34):e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander LE, Garaude J. The mitochondrial respiratory chain: a metabolic rheostat of innate immune cell-mediated antibacterial responses. Mitochondrion. 2018;41:28&#x2013;36. doi: 10.1016/j.mito.2017.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.10.008</ArticleId><ArticleId IdType="pubmed">29054472</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP. Mitochondria: in the cross fire of SARS-CoV-2 and immunity. iScience. 2020;23(10):101631. doi: 10.1016/j.isci.2020.101631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101631</ArticleId><ArticleId IdType="pmc">PMC7524535</ArticleId><ArticleId IdType="pubmed">33015593</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; DePace NL, Colombo J. Autonomic and mitochondrial dysfunction in clinical diseases: diagnostic, prevention, and therapy. Springer Science + Business Media, New York, NY, 2019. This book provides the logic and evidence for the therapies recommended to treat the parasympathetic and sympathetic dysfunctions associated with Long-COVID syndrome.</Citation></Reference><Reference><Citation>Weill P, Plissonneau C, Legrand P, Rioux V, Thibault R. May omega-3 fatty acid dietary supplementation help reduce severe complications in COVID-19 patients? Biochimie. 2020;179:275&#x2013;280. doi: 10.1016/j.biochi.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7481803</ArticleId><ArticleId IdType="pubmed">32920170</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo A, Varzideh F, Wilson S, Gambardella J, Eacobacci M, Jankauskas SS, et al. l-Arginine and COVID-19: an update. Nutrients. 2021;13(11):3951. doi: 10.3390/nu13113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113951</ArticleId><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler D, Gries F. Alpha-lipoic acid and the treatment of diabetic peripheral autonomic cardiac neuropathy. Diabetes. 1997;46(Suppl 2):S62&#x2013;S66. doi: 10.2337/diab.46.2.S62.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.46.2.S62</ArticleId><ArticleId IdType="pubmed">9285502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365&#x2013;2370. doi: 10.2337/dc06-1216.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc06-1216</ArticleId><ArticleId IdType="pubmed">17065669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alphalipoic acid. The SYDNEY trial. Diabetes Care. 2003;26(3):770&#x2013;776. doi: 10.2337/diacare.26.3.770.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.26.3.770</ArticleId><ArticleId IdType="pubmed">12610036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler D, Low PA, Litchy WJ, Boulton AJM, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with &#x3b1;-lipoic acid over 4 years in diabetic polyneuropathy. Diabetes Care. 2011;34:2054&#x2013;2060. doi: 10.2337/dc11-0503.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc11-0503</ArticleId><ArticleId IdType="pmc">PMC3161301</ArticleId><ArticleId IdType="pubmed">21775755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbonnaya S, Kaliaperumal C. Vagal nerve stimulator: evolving trends. J Nat Sci Biol Med. 2013;4(1):8&#x2013;13. doi: 10.4103/0976-9668.107254.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-9668.107254</ArticleId><ArticleId IdType="pmc">PMC3633308</ArticleId><ArticleId IdType="pubmed">23633829</ArticleId></ArticleIdList></Reference><Reference><Citation>Squair JW, Berney M, Castro Jimenez M, Hankov N, Demesmaeker R, Amir S, et al. Implanted system for orthostatic hypotension in multiple-system atrophy. N Engl J Med. 2022;386(14):1339&#x2013;1344. doi: 10.1056/NEJMoa2112809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2112809</ArticleId><ArticleId IdType="pubmed">35388667</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID. Vaccines (Basel). 2022;10(5):652. 10.3390/vaccines10050652. PMID: 35632408; PMCID: PMC9146071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, et al. COVID-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021;385(16):1474&#x2013;1484. doi: 10.1056/NEJMoa2109072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109072</ArticleId><ArticleId IdType="pmc">PMC8362591</ArticleId><ArticleId IdType="pubmed">34320281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert NJ, Survivor Corps. COVID-19 &#x201c;long hauler&#x201d; symptoms survey report. Indiana University School of Medicine; 2020. https://dig.abclocal.go.com/wls/documents/2020/072720-wls-covid-symptom-study-doc.pdf.&#xa0;Accessed 1 Jul 2022.</Citation></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9(12):927&#x2013;937. doi: 10.1016/j.jchf.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>